icgc_specimen_id	project_code	study_specimen_involved_in	submitted_specimen_id	icgc_donor_id	submitted_donor_id	specimen_type	specimen_type_other	specimen_interval	specimen_donor_treatment_type	specimen_donor_treatment_type_other	specimen_processing	specimen_processing_other	specimen_storage	specimen_storage_other	tumour_confirmed	specimen_biobank	specimen_biobank_id	specimen_available	tumour_histological_type	tumour_grading_system	tumour_grade	tumour_grade_supplemental	tumour_stage_system	tumour_stage	tumour_stage_supplemental	digital_image_of_stained_section	percentage_cellularity	level_of_cellularity
SP508	ALL-US		TARGET-10-PAIXPH-10A	DO5	TARGET-10-PAIXPH	Normal - blood derived		29	other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP873	ALL-US		TARGET-10-PAIXPH-03A	DO5	TARGET-10-PAIXPH	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP5	ALL-US		TARGET-10-PAIXPH-09A	DO5	TARGET-10-PAIXPH	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP21	ALL-US		TARGET-10-PAKHZT-03A	DO22	TARGET-10-PAKHZT	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127321	ALL-US		TARGET-10-PAKHZT-60A	DO22	TARGET-10-PAKHZT	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127320	ALL-US		TARGET-10-PAKHZT-60B	DO22	TARGET-10-PAKHZT	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP536	ALL-US		TARGET-10-PAKHZT-10A	DO22	TARGET-10-PAKHZT	Normal - blood derived		29	other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108494	ALL-US		TARGET-10-PAKHZT-14A	DO22	TARGET-10-PAKHZT	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP127324	ALL-US		TARGET-10-PAKMVD-60A	DO48	TARGET-10-PAKMVD	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP560	ALL-US		TARGET-10-PAKMVD-14A	DO48	TARGET-10-PAKMVD	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP47	ALL-US		TARGET-10-PAKMVD-09A	DO48	TARGET-10-PAKMVD	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP49	ALL-US		TARGET-10-PAKMZM-03A	DO50	TARGET-10-PAKMZM	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127326	ALL-US		TARGET-10-PAKMZM-60B	DO50	TARGET-10-PAKMZM	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP562	ALL-US		TARGET-10-PAKMZM-14A	DO50	TARGET-10-PAKMZM	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP127327	ALL-US		TARGET-10-PAKMZM-60A	DO50	TARGET-10-PAKMZM	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127333	ALL-US		TARGET-10-PAKSWW-60A	DO74	TARGET-10-PAKSWW	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP73	ALL-US		TARGET-10-PAKSWW-03A	DO74	TARGET-10-PAKSWW	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP584	ALL-US		TARGET-10-PAKSWW-14A	DO74	TARGET-10-PAKSWW	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP879	ALL-US		TARGET-10-PAKSWW-09A	DO74	TARGET-10-PAKSWW	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP887	ALL-US		TARGET-10-PAKSWW-10A	DO74	TARGET-10-PAKSWW	Normal - blood derived		29	other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP127332	ALL-US		TARGET-10-PAKSWW-60B	DO74	TARGET-10-PAKSWW	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP75	ALL-US		TARGET-10-PAKTAL-03A	DO76	TARGET-10-PAKTAL	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP428	ALL-US		TARGET-10-PAKTAL-09A	DO76	TARGET-10-PAKTAL	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127334	ALL-US		TARGET-10-PAKTAL-60A	DO76	TARGET-10-PAKTAL	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP586	ALL-US		TARGET-10-PAKTAL-14A	DO76	TARGET-10-PAKTAL	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP678	ALL-US		TARGET-10-PALETF-14A	DO162	TARGET-10-PALETF	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP161	ALL-US		TARGET-10-PALETF-03A	DO162	TARGET-10-PALETF	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108499	ALL-US		TARGET-10-PALJDL-14A	DO200	TARGET-10-PALJDL	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP127343	ALL-US		TARGET-10-PALJDL-60B	DO200	TARGET-10-PALJDL	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP198	ALL-US		TARGET-10-PALJDL-09A	DO200	TARGET-10-PALJDL	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP400	ALL-US		TARGET-10-PALJDL-03A	DO200	TARGET-10-PALJDL	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP718	ALL-US		TARGET-10-PALJDL-10A	DO200	TARGET-10-PALJDL	Normal - blood derived		29	other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP127341	ALL-US		TARGET-10-PALJDL-60A	DO200	TARGET-10-PALJDL	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP206	ALL-US		TARGET-10-PALKMM-09A	DO208	TARGET-10-PALKMM	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP728	ALL-US		TARGET-10-PALKMM-14A	DO208	TARGET-10-PALKMM	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP883	ALL-US		TARGET-10-PALKMM-03A	DO208	TARGET-10-PALKMM	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP208	ALL-US		TARGET-10-PALKTY-03A	DO210	TARGET-10-PALKTY	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP729	ALL-US		TARGET-10-PALKTY-14A	DO210	TARGET-10-PALKTY	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP127345	ALL-US		TARGET-10-PALKTY-60A	DO210	TARGET-10-PALKTY	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127346	ALL-US		TARGET-10-PALKTY-60B	DO210	TARGET-10-PALKTY	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127349	ALL-US		TARGET-10-PALLSD-60A	DO228	TARGET-10-PALLSD	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP736	ALL-US		TARGET-10-PALLSD-14A	DO228	TARGET-10-PALLSD	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108500	ALL-US		TARGET-10-PALLSD-03A	DO228	TARGET-10-PALLSD	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127347	ALL-US		TARGET-10-PALLSD-60B	DO228	TARGET-10-PALLSD	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP226	ALL-US		TARGET-10-PALLSD-09A	DO228	TARGET-10-PALLSD	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP774	ALL-US		TARGET-10-PALUAH-14A	DO282	TARGET-10-PALUAH	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP476	ALL-US		TARGET-10-PALUAH-09A	DO282	TARGET-10-PALUAH	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP280	ALL-US		TARGET-10-PALUAH-03A	DO282	TARGET-10-PALUAH	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127357	ALL-US		TARGET-10-PAMDKS-60B	DO376	TARGET-10-PAMDKS	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127356	ALL-US		TARGET-10-PAMDKS-60A	DO376	TARGET-10-PAMDKS	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108502	ALL-US		TARGET-10-PAMDKS-09A	DO376	TARGET-10-PAMDKS	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP848	ALL-US		TARGET-10-PAMDKS-14A	DO376	TARGET-10-PAMDKS	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP374	ALL-US		TARGET-10-PAMDKS-03A	DO376	TARGET-10-PAMDKS	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP402	ALL-US		TARGET-10-PAMDRM-03A	DO378	TARGET-10-PAMDRM	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP376	ALL-US		TARGET-10-PAMDRM-09A	DO378	TARGET-10-PAMDRM	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127359	ALL-US		TARGET-10-PAMDRM-60B	DO378	TARGET-10-PAMDRM	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP127360	ALL-US		TARGET-10-PAMDRM-60A	DO378	TARGET-10-PAMDRM	Xenograft - derived from primary tumour						Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP849	ALL-US		TARGET-10-PAMDRM-14A	DO378	TARGET-10-PAMDRM	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP13659	CLLE-ES	PCAWG	618-1503-04TD	DO6730	618	Primary tumour - blood derived (peripheral blood)		754	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	A				
SP96947	CLLE-ES	PCAWG	618-1503-01ND	DO6730	618	Normal - blood derived		754	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP16220	CLLE-ES	PCAWG	618-1503-05TR	DO6730	618	Primary tumour - blood derived (peripheral blood)		754	no treatment		fresh				yes				9823/3				BINET	A				
SP13665	CLLE-ES		680-1992-01TD	DO6736	680	Primary tumour - blood derived (peripheral blood)		482	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP96950	CLLE-ES		680-1622-01ND	DO6736	680	Normal - blood derived					fresh		other	frozen										Mutated				
SP16263	CLLE-ES		680-1992-02TR	DO6736	680	Primary tumour - blood derived (peripheral blood)		482	no treatment		cryopreservation, other								9823/3					Mutated				
SP16317	CLLE-ES	PCAWG	761-01-3TR	DO6748	761	Primary tumour - blood derived (peripheral blood)		1748	no treatment		fresh				yes				9823/3				BINET	B				
SP96953	CLLE-ES	PCAWG	761-01-5ND	DO6748	761	Normal - blood derived		1748	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP13677	CLLE-ES	PCAWG	761-01-1TD	DO6748	761	Primary tumour - blood derived (peripheral blood)		1748	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP16335	CLLE-ES		785-1836-03TR	DO6754	785	Primary tumour - blood derived (peripheral blood)		8	no treatment		fresh								9823/3					Mutated				
SP13683	CLLE-ES	PCAWG	785-1836-01TD	DO6754	785	Primary tumour - blood derived (peripheral blood)		8	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	A				
SP96954	CLLE-ES	PCAWG	785-1836-04ND	DO6754	785	Normal - blood derived		8	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP96834	CLLE-ES	PCAWG	006-0018-01TD	DO6898	6	Primary tumour - blood derived (peripheral blood)		0	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96835	CLLE-ES	PCAWG	006-0019-01ND	DO6898	6	Normal - blood derived		548	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP96840	CLLE-ES		013-0036-01ND	DO6904	13	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96839	CLLE-ES		013-0035-01TD	DO6904	13	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96853	CLLE-ES		038-0087-01TD	DO6910	38	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96852	CLLE-ES		038-0075-01ND	DO6910	38	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15362	CLLE-ES		042-02-4TR	DO6916	42	Primary tumour - blood derived (peripheral blood)		2514	no treatment		fresh								9823/3					Unmutated				
SP96858	CLLE-ES		042-0091-01TD	DO6916	42	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96857	CLLE-ES		042-0079-01ND	DO6916	42	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96868	CLLE-ES		054-0114-05TD	DO6922	54	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96867	CLLE-ES		054-0114-04ND	DO6922	54	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96875	CLLE-ES		091-01-6TD	DO6928	91	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP96874	CLLE-ES		091-01-3ND	DO6928	91	Normal - blood derived					fresh		other	frozen										Mutated				
SP96881	CLLE-ES	PCAWG	141-02-2ND	DO6934	141	Normal - blood derived		2696	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP96882	CLLE-ES	PCAWG	141-02-3TD	DO6934	141	Primary tumour - blood derived (peripheral blood)		2696	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3				BINET	C				
SP15548	CLLE-ES	PCAWG	145-01-2TR	DO6940	145	Primary tumour - blood derived (peripheral blood)		1399	no treatment		fresh				yes				9823/3				BINET	B				
SP96884	CLLE-ES	PCAWG	145-01-1TD	DO6940	145	Primary tumour - blood derived (peripheral blood)		1399	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96885	CLLE-ES	PCAWG	145-01-6ND	DO6940	145	Normal - blood derived		1399	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP96887	CLLE-ES	PCAWG	148-02-1ND	DO6946	148	Normal - blood derived		156	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP96888	CLLE-ES	PCAWG	148-02-3TD	DO6946	148	Primary tumour - blood derived (peripheral blood)		156	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96894	CLLE-ES		165-01-2ND	DO6952	165	Normal - blood derived					fresh		other	frozen										Mutated				
SP96895	CLLE-ES		165-01-5TD	DO6952	165	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP96905	CLLE-ES		178-01-2TD	DO6958	178	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP96904	CLLE-ES		178-01-1ND	DO6958	178	Normal - blood derived					fresh		other	frozen										Mutated				
SP96921	CLLE-ES		266-01-7TD	DO6964	266	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP96920	CLLE-ES		266-01-2ND	DO6964	266	Normal - blood derived					fresh		other	frozen										Mutated				
SP96925	CLLE-ES		272-01-2TD	DO6970	272	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP96924	CLLE-ES		272-01-1ND	DO6970	272	Normal - blood derived					fresh		other	frozen										Mutated				
SP96932	CLLE-ES		279-01-4TD	DO6976	279	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96931	CLLE-ES		279-01-1ND	DO6976	279	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15884	CLLE-ES		321-01-2TR	DO6982	321	Primary tumour - blood derived (peripheral blood)		64	no treatment		fresh								9823/3					Unmutated				
SP96937	CLLE-ES		321-01-1TD	DO6982	321	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96938	CLLE-ES		321-01-3ND	DO6982	321	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15920	CLLE-ES		328-01-2TR	DO6988	328	Primary tumour - blood derived (peripheral blood)		942	no treatment		fresh								9823/3					Unmutated				
SP96945	CLLE-ES		328-01-3ND	DO6988	328	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96944	CLLE-ES		328-01-1TD	DO6988	328	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96949	CLLE-ES		642-1991-01TD	DO6994	642	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP16238	CLLE-ES		642-1991-02TR	DO6994	642	Primary tumour - blood derived (peripheral blood)		910	no treatment		cryopreservation, other								9823/3					Mutated				
SP96948	CLLE-ES		642-1556-01ND	DO6994	642	Normal - blood derived					fresh		other	frozen										Mutated				
SP96952	CLLE-ES		758-2041-01TD	DO7000	758	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP16311	CLLE-ES		758-03-1TR	DO7000	758	Primary tumour - blood derived (peripheral blood)		2341	combined chemo+immunotherapy		cryopreservation, other								9823/3					Mutated				
SP96951	CLLE-ES		758-1775-01ND	DO7000	758	Normal - blood derived					fresh		other	frozen										Mutated				
SP16569	CMDI-UK	PCAWG	CGP_specimen_1407460	DO7523	CGP_donor_1356858	Primary tumour - other	Not specified																					
SP16570	CMDI-UK	PCAWG	CGP_specimen_1407443	DO7524	CGP_donor_1356841	Primary tumour - other	Not specified																					
SP16571	CMDI-UK	PCAWG	CGP_specimen_1407381	DO7525	CGP_donor_1356779	Primary tumour - other	Not specified																					
SP16572	CMDI-UK	PCAWG	CGP_specimen_1403887	DO7526	CGP_donor_1353459	Primary tumour - other	Not specified																					
SP16573	CMDI-UK	PCAWG	CGP_specimen_1388309	DO7527	CGP_donor_1337981	Primary tumour - other	Not specified																					
SP16574	CMDI-UK	PCAWG	CGP_specimen_849481	DO7528	CGP_donor_831015	Primary tumour - blood derived (bone marrow)																						
SP16576	CMDI-UK	PCAWG	CGP_specimen_1403961	DO7529	CGP_donor_1353533	Primary tumour - other	Not specified																					
SP96970	CMDI-UK	PCAWG	CGP_specimen_1342147	DO7531	CGP_donor_1309187	Normal - other	Not specified																					
SP16578	CMDI-UK	PCAWG	CGP_specimen_1342148	DO7531	CGP_donor_1309187	Primary tumour - other	Not specified																					
SP16580	CMDI-UK	PCAWG	CGP_specimen_1403917	DO7533	CGP_donor_1353489	Primary tumour - other	Not specified																					
SP16582	CMDI-UK	PCAWG	CGP_specimen_1389296	DO7535	CGP_donor_1338959	Primary tumour - other	Not specified																					
SP16584	CMDI-UK	PCAWG	CGP_specimen_1497945	DO7537	CGP_donor_1443182	Cell line - derived from tumour																						
SP16586	CMDI-UK	PCAWG	CGP_specimen_825637	DO7539	CGP_donor_807848	Cell line - derived from tumour																						
SP16588	CMDI-UK	PCAWG	CGP_specimen_1389007	DO7541	CGP_donor_1338679	Primary tumour - other	Not specified																					
SP16590	CMDI-UK	PCAWG	CGP_specimen_1388618	DO7543	CGP_donor_1338290	Primary tumour - other	Not specified																					
SP96973	CMDI-UK	PCAWG	CGP_specimen_1516556	DO7545	CGP_donor_1353582	Normal - other	Not specified																					
SP16592	CMDI-UK	PCAWG	CGP_specimen_1404010	DO7545	CGP_donor_1353582	Primary tumour - other	Not specified																					
SP96962	CMDI-UK	PCAWG	CGP_specimen_1244886	DO7547	CGP_donor_1215616	Normal - other	Not specified																					
SP16594	CMDI-UK	PCAWG	CGP_specimen_1244885	DO7547	CGP_donor_1215616	Primary tumour - other	Not specified																					
SP16596	CMDI-UK	PCAWG	CGP_specimen_1244893	DO7549	CGP_donor_1215620	Primary tumour - other	Not specified																					
SP96964	CMDI-UK	PCAWG	CGP_specimen_1244894	DO7549	CGP_donor_1215620	Normal - other	Not specified																					
SP16598	CMDI-UK	PCAWG	CGP_specimen_1497946	DO7551	CGP_donor_1443183	Primary tumour - other	Not specified																					
SP16600	CMDI-UK	PCAWG	CGP_specimen_1403953	DO7553	CGP_donor_1353525	Primary tumour - other	Not specified																					
SP16602	CMDI-UK	PCAWG	CGP_specimen_1403949	DO7555	CGP_donor_1353521	Primary tumour - other	Not specified																					
SP16604	CMDI-UK	PCAWG	CGP_specimen_1403946	DO7557	CGP_donor_1353518	Primary tumour - other	Not specified																					
SP16606	CMDI-UK	PCAWG	CGP_specimen_1403942	DO7559	CGP_donor_1353514	Primary tumour - other	Not specified																					
SP16608	CMDI-UK	PCAWG	CGP_specimen_1388770	DO7561	CGP_donor_1338442	Primary tumour - other	Not specified																					
SP16610	CMDI-UK	PCAWG	CGP_specimen_1388767	DO7563	CGP_donor_1338439	Primary tumour - other	Not specified																					
SP16612	CMDI-UK	PCAWG	CGP_specimen_1388299	DO7565	CGP_donor_1337971	Primary tumour - other	Not specified																					
SP96968	CMDI-UK	PCAWG	CGP_specimen_1267829	DO7567	CGP_donor_1234827	Normal - other	Not specified																					
SP16614	CMDI-UK	PCAWG	CGP_specimen_1267828	DO7567	CGP_donor_1234827	Primary tumour - other	Not specified																					
SP16616	CMDI-UK	PCAWG	CGP_specimen_1192107	DO7569	CGP_donor_1163904	Primary tumour - other	Not specified																					
SP96959	CMDI-UK	PCAWG	CGP_specimen_1192108	DO7569	CGP_donor_1163904	Normal - other	Not specified																					
SP96961	CMDI-UK	PCAWG	CGP_specimen_1244884	DO7571	CGP_donor_1215615	Normal - other	Not specified																					
SP16618	CMDI-UK	PCAWG	CGP_specimen_1244883	DO7571	CGP_donor_1215615	Primary tumour - other	Not specified																					
SP16620	CMDI-UK	PCAWG	CGP_specimen_1403978	DO7573	CGP_donor_1353550	Primary tumour - other	Not specified																					
SP16622	CMDI-UK	PCAWG	CGP_specimen_1403962	DO7575	CGP_donor_1353534	Primary tumour - other	Not specified																					
SP16624	CMDI-UK	PCAWG	CGP_specimen_1403872	DO7577	CGP_donor_1353444	Primary tumour - other	Not specified																					
SP16626	CMDI-UK	PCAWG	CGP_specimen_825965	DO7579	CGP_donor_808176	Cell line - derived from tumour																						
SP96956	CMDI-UK	PCAWG	CGP_specimen_865022	DO7581	CGP_donor_846424	Normal - solid tissue																						
SP16628	CMDI-UK	PCAWG	CGP_specimen_865021	DO7581	CGP_donor_846424	Primary tumour - solid tissue																						
SP16630	CMDI-UK	PCAWG	CGP_specimen_828435	DO7583	CGP_donor_810652	Cell line - derived from tumour																						
SP16632	CMDI-UK	PCAWG	CGP_specimen_1407467	DO7585	CGP_donor_1356865	Primary tumour - other	Not specified																					
SP16634	CMDI-UK	PCAWG	CGP_specimen_1407456	DO7587	CGP_donor_1356854	Primary tumour - other	Not specified																					
SP16636	CMDI-UK	PCAWG	CGP_specimen_1407421	DO7589	CGP_donor_1356819	Primary tumour - other	Not specified																					
SP16638	CMDI-UK	PCAWG	CGP_specimen_1407418	DO7591	CGP_donor_1356816	Primary tumour - other	Not specified																					
SP16640	CMDI-UK	PCAWG	CGP_specimen_1403976	DO7593	CGP_donor_1353548	Primary tumour - other	Not specified																					
SP16642	CMDI-UK	PCAWG	CGP_specimen_1403966	DO7595	CGP_donor_1353538	Primary tumour - other	Not specified																					
SP16644	CMDI-UK	PCAWG	CGP_specimen_1403955	DO7597	CGP_donor_1353527	Primary tumour - other	Not specified																					
SP16646	CMDI-UK	PCAWG	CGP_specimen_1403905	DO7599	CGP_donor_1353477	Primary tumour - other	Not specified																					
SP16648	CMDI-UK	PCAWG	CGP_specimen_1403878	DO7601	CGP_donor_1353450	Primary tumour - other	Not specified																					
SP16650	CMDI-UK	PCAWG	CGP_specimen_1389006	DO7603	CGP_donor_1338678	Primary tumour - other	Not specified																					
SP16652	CMDI-UK	PCAWG	CGP_specimen_1388308	DO7605	CGP_donor_1337980	Primary tumour - other	Not specified																					
SP16654	CMDI-UK	PCAWG	CGP_specimen_1266756	DO7607	CGP_donor_1234205	Primary tumour - other	Not specified																					
SP96967	CMDI-UK	PCAWG	CGP_specimen_1266757	DO7607	CGP_donor_1234205	Normal - other	Not specified																					
SP16656	CMDI-UK	PCAWG	CGP_specimen_1403920	DO7609	CGP_donor_1353492	Primary tumour - other	Not specified																					
SP96958	CMDI-UK	PCAWG	CGP_specimen_1004965	DO7611	CGP_donor_980848	Normal - other	Not specified																					
SP16658	CMDI-UK	PCAWG	CGP_specimen_1004978	DO7611	CGP_donor_980848	Primary tumour - other	Not specified																					
SP96965	CMDI-UK	PCAWG	CGP_specimen_1244898	DO7613	CGP_donor_1215622	Normal - other	Not specified																					
SP16660	CMDI-UK	PCAWG	CGP_specimen_1244897	DO7613	CGP_donor_1215622	Primary tumour - other	Not specified																					
SP16662	CMDI-UK	PCAWG	CGP_specimen_1342108	DO7615	CGP_donor_1309158	Primary tumour - other	Not specified																					
SP96969	CMDI-UK	PCAWG	CGP_specimen_1342109	DO7615	CGP_donor_1309158	Normal - other	Not specified																					
SP16664	CMDI-UK	PCAWG	CGP_specimen_1403971	DO7617	CGP_donor_1353543	Primary tumour - other	Not specified																					
SP16666	CMDI-UK	PCAWG	CGP_specimen_1403899	DO7619	CGP_donor_1353471	Primary tumour - other	Not specified																					
SP96960	CMDI-UK	PCAWG	CGP_specimen_1206809	DO7621	CGP_donor_1178368	Normal - other	Not specified																					
SP16668	CMDI-UK	PCAWG	CGP_specimen_1206808	DO7621	CGP_donor_1178368	Primary tumour - other	Not specified																					
SP16670	CMDI-UK	PCAWG	CGP_specimen_1403935	DO7623	CGP_donor_1353507	Primary tumour - other	Not specified																					
SP96972	CMDI-UK	PCAWG	CGP_specimen_1490505	DO7623	CGP_donor_1353507	Normal - other	Not specified																					
SP16672	CMDI-UK	PCAWG	CGP_specimen_1388755	DO7625	CGP_donor_1338427	Primary tumour - other	Not specified																					
SP96971	CMDI-UK	PCAWG	CGP_specimen_1439862	DO7627	CGP_donor_1353496	Normal - blood derived	Not specified																					
SP16674	CMDI-UK	PCAWG	CGP_specimen_1403924	DO7627	CGP_donor_1353496	Primary tumour - other	Not specified																					
SP96974	CMDI-UK	PCAWG	CGP_specimen_1516557	DO7629	CGP_donor_1353583	Normal - other	Not specified																					
SP16676	CMDI-UK	PCAWG	CGP_specimen_1404011	DO7629	CGP_donor_1353583	Primary tumour - other	Not specified																					
SP16678	CMDI-UK	PCAWG	CGP_specimen_1407390	DO7631	CGP_donor_1356788	Primary tumour - other	Not specified																					
SP16680	CMDI-UK	PCAWG	CGP_specimen_1244887	DO7633	CGP_donor_1215617	Primary tumour - other	Not specified																					
SP96963	CMDI-UK	PCAWG	CGP_specimen_1244888	DO7633	CGP_donor_1215617	Normal - other	Not specified																					
SP16682	CMDI-UK	PCAWG	CGP_specimen_1407493	DO7635	CGP_donor_1356891	Primary tumour - other	Not specified																					
SP16684	CMDI-UK	PCAWG	CGP_specimen_1407451	DO7637	CGP_donor_1356849	Primary tumour - other	Not specified																					
SP16686	CMDI-UK	PCAWG	CGP_specimen_1403892	DO7639	CGP_donor_1353464	Primary tumour - other	Not specified																					
SP16688	CMDI-UK	PCAWG	CGP_specimen_1389186	DO7641	CGP_donor_1338849	Primary tumour - other	Not specified																					
SP16690	CMDI-UK	PCAWG	CGP_specimen_1407377	DO7643	CGP_donor_1356775	Primary tumour - other	Not specified																					
SP16692	CMDI-UK	PCAWG	CGP_specimen_1403867	DO7645	CGP_donor_1353439	Primary tumour - other	Not specified																					
SP16694	CMDI-UK	PCAWG	CGP_specimen_672559	DO7647	CGP_donor_653597	Cell line - derived from tumour																						
SP16696	CMDI-UK	PCAWG	CGP_specimen_1407485	DO7649	CGP_donor_1356883	Primary tumour - other	Not specified																					
SP16698	CMDI-UK	PCAWG	CGP_specimen_1407492	DO7651	CGP_donor_1356890	Primary tumour - other	Not specified																					
SP16700	CMDI-UK	PCAWG	CGP_specimen_1407403	DO7653	CGP_donor_1356801	Primary tumour - other	Not specified																					
SP16702	CMDI-UK	PCAWG	CGP_specimen_1404012	DO7655	CGP_donor_1353584	Primary tumour - other	Not specified																					
SP16704	CMDI-UK	PCAWG	CGP_specimen_1403964	DO7657	CGP_donor_1353536	Primary tumour - other	Not specified																					
SP16706	CMDI-UK	PCAWG	CGP_specimen_1403933	DO7659	CGP_donor_1353505	Primary tumour - other	Not specified																					
SP16708	CMDI-UK	PCAWG	CGP_specimen_1403907	DO7661	CGP_donor_1353479	Primary tumour - other	Not specified																					
SP16710	CMDI-UK	PCAWG	CGP_specimen_1389297	DO7663	CGP_donor_1338960	Primary tumour - other	Not specified																					
SP16712	CMDI-UK	PCAWG	CGP_specimen_1389242	DO7665	CGP_donor_1338905	Primary tumour - other	Not specified																					
SP16714	CMDI-UK	PCAWG	CGP_specimen_1407405	DO7667	CGP_donor_1356803	Primary tumour - other	Not specified																					
SP16716	CMDI-UK	PCAWG	CGP_specimen_1244899	DO7669	CGP_donor_1215623	Primary tumour - other	Not specified																					
SP96966	CMDI-UK	PCAWG	CGP_specimen_1244900	DO7669	CGP_donor_1215623	Normal - other	Not specified																					
SP16718	CMDI-UK	PCAWG	CGP_specimen_672522	DO7671	CGP_donor_653560	Cell line - derived from tumour																						
SP96955	CMDI-UK	PCAWG	CGP_specimen_829284	DO7671	CGP_donor_653560	Normal - other	Not specified																					
SP16720	CMDI-UK	PCAWG	CGP_specimen_1389249	DO7673	CGP_donor_1338912	Primary tumour - other	Not specified																					
SP16722	CMDI-UK	PCAWG	CGP_specimen_1407494	DO7675	CGP_donor_1356892	Primary tumour - other	Not specified																					
SP16724	CMDI-UK	PCAWG	CGP_specimen_1407489	DO7677	CGP_donor_1356887	Primary tumour - other	Not specified																					
SP16726	CMDI-UK	PCAWG	CGP_specimen_1407471	DO7679	CGP_donor_1356869	Primary tumour - other	Not specified																					
SP16728	CMDI-UK	PCAWG	CGP_specimen_1403957	DO7681	CGP_donor_1353529	Primary tumour - other	Not specified																					
SP16730	CMDI-UK	PCAWG	CGP_specimen_1403883	DO7683	CGP_donor_1353455	Primary tumour - other	Not specified																					
SP16732	CMDI-UK	PCAWG	CGP_specimen_1389014	DO7685	CGP_donor_1338686	Primary tumour - other	Not specified																					
SP16734	CMDI-UK	PCAWG	CGP_specimen_961562	DO7687	CGP_donor_938551	Primary tumour - other	Not specified																					
SP96957	CMDI-UK	PCAWG	CGP_specimen_961501	DO7687	CGP_donor_938551	Normal - other	Not specified																					
SP16736	CMDI-UK	PCAWG	CGP_specimen_1389294	DO7689	CGP_donor_1338957	Primary tumour - other	Not specified																					
SP16738	CMDI-UK	PCAWG	CGP_specimen_1388567	DO7691	CGP_donor_1338239	Primary tumour - other	Not specified																					
SP16740	CMDI-UK	PCAWG	CGP_specimen_1389248	DO7693	CGP_donor_1338911	Primary tumour - other	Not specified																					
SP16742	CMDI-UK	PCAWG	CGP_specimen_1403898	DO7695	CGP_donor_1353470	Primary tumour - other	Not specified																					
SP16744	CMDI-UK	PCAWG	CGP_specimen_1388316	DO7697	CGP_donor_1337988	Primary tumour - other	Not specified																					
SP16746	CMDI-UK	PCAWG	CGP_specimen_668688	DO7699	CGP_donor_649726	Cell line - derived from tumour																						
SP16748	CMDI-UK	PCAWG	CGP_specimen_1407380	DO7701	CGP_donor_1356778	Primary tumour - other	Not specified																					
SP16750	CMDI-UK	PCAWG	CGP_specimen_1403944	DO7703	CGP_donor_1353516	Primary tumour - other	Not specified																					
SP16752	CMDI-UK	PCAWG	CGP_specimen_1403904	DO7705	CGP_donor_1353476	Primary tumour - other	Not specified																					
SP16754	CMDI-UK	PCAWG	CGP_specimen_1403939	DO7707	CGP_donor_1353511	Primary tumour - other	Not specified																					
SP16756	CMDI-UK	PCAWG	CGP_specimen_1389207	DO7709	CGP_donor_1338870	Primary tumour - other	Not specified																					
SP16758	CMDI-UK	PCAWG	CGP_specimen_1403874	DO7711	CGP_donor_1353446	Primary tumour - other	Not specified																					
SP16760	CMDI-UK	PCAWG	CGP_specimen_1407454	DO7713	CGP_donor_1356852	Primary tumour - other	Not specified																					
SP16762	CMDI-UK	PCAWG	CGP_specimen_1407420	DO7715	CGP_donor_1356818	Primary tumour - other	Not specified																					
SP16764	CMDI-UK	PCAWG	CGP_specimen_1407415	DO7717	CGP_donor_1356813	Primary tumour - other	Not specified																					
SP16766	CMDI-UK	PCAWG	CGP_specimen_1403954	DO7719	CGP_donor_1353526	Primary tumour - other	Not specified																					
SP16768	CMDI-UK	PCAWG	CGP_specimen_1403896	DO7721	CGP_donor_1353468	Primary tumour - other	Not specified																					
SP16770	CMDI-UK	PCAWG	CGP_specimen_1389241	DO7723	CGP_donor_1338904	Primary tumour - other	Not specified																					
SP16772	CMDI-UK	PCAWG	CGP_specimen_824512	DO7725	CGP_donor_806717	Cell line - derived from tumour																						
SP16774	CMDI-UK	PCAWG	CGP_specimen_1389005	DO7727	CGP_donor_1338677	Primary tumour - other	Not specified																					
SP16776	CMDI-UK	PCAWG	CGP_specimen_1388565	DO7729	CGP_donor_1338237	Primary tumour - other	Not specified																					
SP16778	CMDI-UK	PCAWG	CGP_specimen_1342137	DO7731	CGP_donor_1309177	Primary tumour - other	Not specified																					
SP16780	CMDI-UK	PCAWG	CGP_specimen_1415103	DO7733	CGP_donor_1364188	Primary tumour - other	Not specified																					
SP16782	CMDI-UK	PCAWG	CGP_specimen_1415106	DO7735	CGP_donor_1364191	Primary tumour - other	Not specified																					
SP16784	CMDI-UK	PCAWG	CGP_specimen_1415083	DO7737	CGP_donor_1364168	Primary tumour - other	Not specified																					
SP16786	CMDI-UK	PCAWG	CGP_specimen_1415124	DO7739	CGP_donor_1364209	Primary tumour - other	Not specified																					
SP16788	CMDI-UK	PCAWG	CGP_specimen_1415099	DO7741	CGP_donor_1364184	Primary tumour - other	Not specified																					
SP16790	CMDI-UK	PCAWG	CGP_specimen_1415123	DO7743	CGP_donor_1364208	Primary tumour - other	Not specified																					
SP16792	CMDI-UK	PCAWG	CGP_specimen_1415084	DO7745	CGP_donor_1364169	Primary tumour - other	Not specified																					
SP16794	CMDI-UK	PCAWG	CGP_specimen_1415120	DO7747	CGP_donor_1364205	Primary tumour - other	Not specified																					
SP16796	CMDI-UK	PCAWG	CGP_specimen_1415080	DO7749	CGP_donor_1364165	Primary tumour - other	Not specified																					
SP16798	CMDI-UK	PCAWG	CGP_specimen_1415109	DO7751	CGP_donor_1364194	Primary tumour - other	Not specified																					
SP16800	CMDI-UK	PCAWG	CGP_specimen_1415078	DO7753	CGP_donor_1364163	Primary tumour - other	Not specified																					
SP16802	CMDI-UK	PCAWG	CGP_specimen_1415094	DO7755	CGP_donor_1364179	Primary tumour - other	Not specified																					
SP16804	CMDI-UK	PCAWG	CGP_specimen_1415102	DO7757	CGP_donor_1364187	Primary tumour - other	Not specified																					
SP16806	CMDI-UK	PCAWG	CGP_specimen_1415140	DO7759	CGP_donor_1364225	Primary tumour - other	Not specified																					
SP16808	CMDI-UK	PCAWG	CGP_specimen_1415100	DO7761	CGP_donor_1364185	Primary tumour - other	Not specified																					
SP16810	CMDI-UK	PCAWG	CGP_specimen_1415116	DO7763	CGP_donor_1364201	Primary tumour - other	Not specified																					
SP16812	CMDI-UK	PCAWG	CGP_specimen_1415142	DO7765	CGP_donor_1364227	Primary tumour - other	Not specified																					
SP16814	CMDI-UK	PCAWG	CGP_specimen_1415092	DO7767	CGP_donor_1364177	Primary tumour - other	Not specified																					
SP16816	CMDI-UK	PCAWG	CGP_specimen_1415113	DO7769	CGP_donor_1364198	Primary tumour - other	Not specified																					
SP16818	CMDI-UK	PCAWG	CGP_specimen_1415138	DO7771	CGP_donor_1364223	Primary tumour - other	Not specified																					
SP16820	CMDI-UK	PCAWG	CGP_specimen_1415085	DO7773	CGP_donor_1364170	Primary tumour - other	Not specified																					
SP59269	MALY-DE	PCAWG	control_4182393	DO27763	4182393	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59270	MALY-DE	PCAWG	tumor_4182393	DO27763	4182393	Primary tumour - lymph node		1	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			90	
SP59272	MALY-DE	PCAWG	tumor_4119027	DO27764	4119027	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			95	
SP59271	MALY-DE	PCAWG	control_4119027	DO27764	4119027	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59274	MALY-DE	PCAWG	control_4125240	DO27765	4125240	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59276	MALY-DE	PCAWG	tumor_4125240	DO27765	4125240	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			80	
SP59280	MALY-DE	PCAWG	tumor_4190495	DO27767	4190495	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			70	
SP59278	MALY-DE	PCAWG	control_4190495	DO27767	4190495	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59284	MALY-DE	PCAWG	tumor_4189998	DO27769	4189998	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			75	
SP59282	MALY-DE	PCAWG	control_4189998	DO27769	4189998	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59288	MALY-DE	PCAWG	tumor_4135350	DO27771	4135350	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9590/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			85	
SP59286	MALY-DE	PCAWG	control_4135350	DO27771	4135350	Normal - blood derived		1553	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59290	MALY-DE	PCAWG	control_4159170	DO27773	4159170	Normal - blood derived		1470	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59292	MALY-DE	PCAWG	tumor_4159170	DO27773	4159170	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			70	
SP59296	MALY-DE	PCAWG	tumor_4194218	DO27775	4194218	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			70	
SP59294	MALY-DE	PCAWG	control_4194218	DO27775	4194218	Normal - bone marrow		1	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59300	MALY-DE	PCAWG	tumor_4116738	DO27777	4116738	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade ib		unknown	unknown			65	
SP59298	MALY-DE	PCAWG	control_4116738	DO27777	4116738	Normal - blood derived		1422	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59304	MALY-DE	PCAWG	tumor_4163639	DO27779	4163639	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			80	
SP59302	MALY-DE	PCAWG	control_4163639	DO27779	4163639	Normal - blood derived		828	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59308	MALY-DE	PCAWG	tumor_4105105	DO27781	4105105	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			70	
SP59306	MALY-DE	PCAWG	control_4105105	DO27781	4105105	Normal - blood derived		516	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59316	MALY-DE	PCAWG	tumor_4189200	DO27785	4189200	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			60	
SP59314	MALY-DE	PCAWG	control_4189200	DO27785	4189200	Normal - blood derived		1925	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59320	MALY-DE	PCAWG	tumor_4175837	DO27787	4175837	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9698/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade IIIa		unknown	unknown			70	
SP59318	MALY-DE	PCAWG	control_4175837	DO27787	4175837	Normal - blood derived		420	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59324	MALY-DE	PCAWG	tumor_4108101	DO27789	4108101	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			70	
SP59322	MALY-DE	PCAWG	control_4108101	DO27789	4108101	Normal - blood derived		292	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59330	MALY-DE	PCAWG	control_4146289	DO27793	4146289	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59332	MALY-DE	PCAWG	tumor_4146289	DO27793	4146289	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			60	
SP59334	MALY-DE	PCAWG	control_4112512	DO27795	4112512	Normal - blood derived		1258	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59336	MALY-DE	PCAWG	tumor_4112512	DO27795	4112512	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			80	
SP59340	MALY-DE	PCAWG	tumor_4158726	DO27797	4158726	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			70	
SP59338	MALY-DE	PCAWG	control_4158726	DO27797	4158726	Normal - blood derived		449	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59342	MALY-DE	PCAWG	control_4193278	DO27799	4193278	Normal - bone marrow		5	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59344	MALY-DE	PCAWG	tumor_4193278	DO27799	4193278	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			85	
SP59346	MALY-DE	PCAWG	control_4121361	DO27801	4121361	Normal - blood derived		123	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59348	MALY-DE	PCAWG	tumor_4121361	DO27801	4121361	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			80	
SP59352	MALY-DE	PCAWG	tumor_4134005	DO27803	4134005	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			80	
SP59350	MALY-DE	PCAWG	control_4134005	DO27803	4134005	Normal - blood derived		496	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59354	MALY-DE	PCAWG	control_4188900	DO27805	4188900	Normal - blood derived		420	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59356	MALY-DE	PCAWG	tumor_4188900	DO27805	4188900	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			75	
SP59358	MALY-DE	PCAWG	control_4104893	DO27807	4104893	Normal - bone marrow		5	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59360	MALY-DE	PCAWG	tumor_4104893	DO27807	4104893	Primary tumour - lymph node		5	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			85	
SP59364	MALY-DE	PCAWG	tumor_4177376	DO27809	4177376	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			65	
SP59362	MALY-DE	PCAWG	control_4177376	DO27809	4177376	Normal - blood derived		154	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59366	MALY-DE	PCAWG	control_4135099	DO27811	4135099	Normal - blood derived		596	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59368	MALY-DE	PCAWG	tumor_4135099	DO27811	4135099	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			80	
SP59372	MALY-DE	PCAWG	tumor_4101316	DO27813	4101316	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			60	
SP59370	MALY-DE	PCAWG	control_4101316	DO27813	4101316	Normal - blood derived		111	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59376	MALY-DE	PCAWG	tumor_4177434	DO27815	4177434	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			85	
SP59374	MALY-DE	PCAWG	control_4177434	DO27815	4177434	Normal - blood derived		639	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59378	MALY-DE	PCAWG	control_4177987	DO27817	4177987	Normal - blood derived		0	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59380	MALY-DE	PCAWG	tumor_4177987	DO27817	4177987	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9691/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade II		unknown	unknown			70	
SP59382	MALY-DE	PCAWG	control_4133511	DO27819	4133511	Normal - blood derived		2189	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59384	MALY-DE	PCAWG	tumor_4133511	DO27819	4133511	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			80	
SP59386	MALY-DE	PCAWG	control_4177856	DO27821	4177856	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59388	MALY-DE	PCAWG	tumor_4177856	DO27821	4177856	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			90	
SP59392	MALY-DE	PCAWG	tumor_4142267	DO27823	4142267	Primary tumour - blood derived (bone marrow)		1	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			70	
SP59390	MALY-DE	PCAWG	control_4142267	DO27823	4142267	Normal - bone marrow		31	other therapy	retrospective after treatment	fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59396	MALY-DE	PCAWG	tumor_4194891	DO27825	4194891	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			85	
SP59394	MALY-DE	PCAWG	control_4194891	DO27825	4194891	Normal - bone marrow		0	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59400	MALY-DE	PCAWG	tumor_4107137	DO27827	4107137	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			70	
SP59398	MALY-DE	PCAWG	control_4107137	DO27827	4107137	Normal - blood derived		1009	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59402	MALY-DE	PCAWG	control_4127766	DO27829	4127766	Normal - bone marrow		2	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59404	MALY-DE	PCAWG	tumor_4127766	DO27829	4127766	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9687/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			85	
SP59410	MALY-DE	PCAWG	control_4102009	DO27833	4102009	Normal - blood derived		1532	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59412	MALY-DE	PCAWG	tumor_4102009	DO27833	4102009	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			75	
SP59414	MALY-DE	PCAWG	control_4160468	DO27835	4160468	Normal - blood derived		2396	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59416	MALY-DE	PCAWG	tumor_4160468	DO27835	4160468	Primary tumour - lymph node		1858	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9691/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade II		unknown	unknown			75	
SP59418	MALY-DE	PCAWG	control_4170686	DO27837	4170686	Normal - blood derived		750	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59420	MALY-DE	PCAWG	tumor_4170686	DO27837	4170686	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			80	
SP59430	MALY-DE	PCAWG	control_4174905	DO27843	4174905	Normal - blood derived		1212	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59432	MALY-DE	PCAWG	tumor_4174905	DO27843	4174905	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9695/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade I		unknown	unknown			75	
SP59434	MALY-DE	PCAWG	control_4177601	DO27845	4177601	Normal - blood derived		659	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59436	MALY-DE	PCAWG	tumor_4177601	DO27845	4177601	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9691/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade II		unknown	unknown			60	
SP59440	MALY-DE	PCAWG	tumor_4191799	DO27847	4191799	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9679/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	unknown		unknown	unknown			80	
SP59438	MALY-DE	PCAWG	control_4191799	DO27847	4191799	Normal - bone marrow		3	no treatment		fresh		other	frozen, -80 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59444	MALY-DE	PCAWG	tumor_4139696	DO27849	4139696	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9698/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	FL grade IIIb		unknown	unknown				
SP59442	MALY-DE	PCAWG	control_4139696	DO27849	4139696	Normal - blood derived		0	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59448	MALY-DE	PCAWG	tumor_4120193	DO27851	4120193	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			60	
SP59446	MALY-DE	PCAWG	control_4120193	DO27851	4120193	Normal - blood derived		2551	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59452	MALY-DE	PCAWG	tumor_4166706	DO27853	4166706	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			70	
SP59450	MALY-DE	PCAWG	control_4166706	DO27853	4166706	Normal - blood derived		108	other therapy	retrospective after treatment	fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59454	MALY-DE	PCAWG	control_4176133	DO27855	4176133	Normal - blood derived		6	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP59456	MALY-DE	PCAWG	tumor_4176133	DO27855	4176133	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			70	
SP59460	MALY-DE	PCAWG	tumor_4184094	DO27857	4184094	Primary tumour - lymph node		0	no treatment		cryopreservation in dry ice (dead tissue)		other	frozen, -80 degrees Celsius freezer	yes				9680/3	WHO-Classification of Tumours of Haematopoietic and Lymphoid Tissues	DLBCL grade cb		unknown	unknown			75	
SP59458	MALY-DE	PCAWG	control_4184094	DO27857	4184094	Normal - blood derived		0	no treatment		fresh		other	frozen, -20 degrees Celsius freezer	no					unknown	unknown		unknown	unknown				
SP108557	ALL-US		TARGET-10-PAPJIB-14A	DO49287	TARGET-10-PAPJIB	Normal - bone marrow			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108259	ALL-US		TARGET-10-PAPJIB-04A	DO49287	TARGET-10-PAPJIB	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108260	ALL-US		TARGET-10-PAPJIB-09A	DO49287	TARGET-10-PAPJIB	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108484	ALL-US		TARGET-10-PAPLDL-09A	DO49292	TARGET-10-PAPLDL	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108269	ALL-US		TARGET-10-PAPLDL-04A	DO49292	TARGET-10-PAPLDL	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108268	ALL-US		TARGET-10-PAPLDL-03A	DO49292	TARGET-10-PAPLDL	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108562	ALL-US		TARGET-10-PAPLDL-10A	DO49292	TARGET-10-PAPLDL	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108579	ALL-US		TARGET-10-PAPSPG-10A	DO49309	TARGET-10-PAPSPG	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108296	ALL-US		TARGET-10-PAPSPG-04A	DO49309	TARGET-10-PAPSPG	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108297	ALL-US		TARGET-10-PAPSPG-09A	DO49309	TARGET-10-PAPSPG	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108585	ALL-US		TARGET-10-PAPZNK-03A	DO49320	TARGET-10-PAPZNK	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108586	ALL-US		TARGET-10-PAPZNK-10A	DO49320	TARGET-10-PAPZNK	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108313	ALL-US		TARGET-10-PAPZNK-04A	DO49320	TARGET-10-PAPZNK	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108314	ALL-US		TARGET-10-PAPZNK-09A	DO49320	TARGET-10-PAPZNK	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108593	ALL-US		TARGET-10-PARAKF-10A	DO49323	TARGET-10-PARAKF	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108318	ALL-US		TARGET-10-PARAKF-04A	DO49323	TARGET-10-PARAKF	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108319	ALL-US		TARGET-10-PARAKF-09A	DO49323	TARGET-10-PARAKF	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108324	ALL-US		TARGET-10-PARBRK-09A	DO49326	TARGET-10-PARBRK	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108598	ALL-US		TARGET-10-PARBRK-10A	DO49326	TARGET-10-PARBRK	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108323	ALL-US		TARGET-10-PARBRK-04A	DO49326	TARGET-10-PARBRK	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108337	ALL-US		TARGET-10-PARFTR-09A	DO49334	TARGET-10-PARFTR	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108336	ALL-US		TARGET-10-PARFTR-04A	DO49334	TARGET-10-PARFTR	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108604	ALL-US		TARGET-10-PARFTR-10A	DO49334	TARGET-10-PARFTR	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108349	ALL-US		TARGET-10-PARIAD-03A	DO49341	TARGET-10-PARIAD	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108350	ALL-US		TARGET-10-PARIAD-04A	DO49341	TARGET-10-PARIAD	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108617	ALL-US		TARGET-10-PARIAD-10A	DO49341	TARGET-10-PARIAD	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108353	ALL-US		TARGET-10-PARJZZ-04A	DO49343	TARGET-10-PARJZZ	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108354	ALL-US		TARGET-10-PARJZZ-09A	DO49343	TARGET-10-PARJZZ	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108619	ALL-US		TARGET-10-PARJZZ-10A	DO49343	TARGET-10-PARJZZ	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108373	ALL-US		TARGET-10-PARPNM-09A	DO49355	TARGET-10-PARPNM	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108632	ALL-US		TARGET-10-PARPNM-10A	DO49355	TARGET-10-PARPNM	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108372	ALL-US		TARGET-10-PARPNM-04A	DO49355	TARGET-10-PARPNM	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108633	ALL-US		TARGET-10-PARPRW-10A	DO49357	TARGET-10-PARPRW	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108375	ALL-US		TARGET-10-PARPRW-04A	DO49357	TARGET-10-PARPRW	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108376	ALL-US		TARGET-10-PARPRW-09A	DO49357	TARGET-10-PARPRW	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108407	ALL-US		TARGET-10-PASFXA-03A	DO49380	TARGET-10-PASFXA	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108408	ALL-US		TARGET-10-PASFXA-04A	DO49380	TARGET-10-PASFXA	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108656	ALL-US		TARGET-10-PASFXA-10A	DO49380	TARGET-10-PASFXA	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108661	ALL-US		TARGET-10-PASLZM-10A	DO49384	TARGET-10-PASLZM	Normal - blood derived			other therapy	Assume systemic therapies, but normal confirmed free of tumor cells before banking		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3														
SP108492	ALL-US		TARGET-10-PASLZM-03A	DO49384	TARGET-10-PASLZM	Primary tumour - blood derived (peripheral blood)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108415	ALL-US		TARGET-10-PASLZM-09A	DO49384	TARGET-10-PASLZM	Primary tumour - blood derived (bone marrow)		0	no treatment			Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108493	ALL-US		TARGET-10-PASLZM-04A	DO49384	TARGET-10-PASLZM	Recurrent tumour - blood derived (bone marrow)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP108416	ALL-US		TARGET-10-PASLZM-40A	DO49384	TARGET-10-PASLZM	Recurrent tumour - blood derived (peripheral blood)			other therapy	Assume systemic therapies prior to recurrence		Known to be cryopreservation by method 1, 2, or 4		Known to be cryostorage by method 1, 2, or 3	yes				9835/3									
SP15182	CLLE-ES	PCAWG	001-0002-09TR	DO6350	1	Primary tumour - blood derived (peripheral blood)		1977	no treatment		cryopreservation, other				yes				9823/3				BINET	C				
SP96826	CLLE-ES		001-0002-03TD	DO6350	1	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Unmutated				
SP96829	CLLE-ES	PCAWG	001-0004-14ND	DO6350	1	Normal - blood derived		3957	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13278	CLLE-ES	PCAWG	001-0002-11TD	DO6350	1	Primary tumour - blood derived (peripheral blood)		1977	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96828	CLLE-ES		001-0001-01ND	DO6350	1	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13280	CLLE-ES	PCAWG	003-0005-10TD	DO6352	3	Primary tumour - blood derived (peripheral blood)		79	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96827	CLLE-ES		003-0005-09TD	DO6352	3	Primary tumour - blood derived (peripheral blood)					fresh		other	frozen					9823/3					Mutated				
SP96830	CLLE-ES	PCAWG	003-0009-01ND	DO6352	3	Normal - blood derived		2317	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15194	CLLE-ES	PCAWG	003-0005-08TR	DO6352	3	Primary tumour - blood derived (peripheral blood)		79	no treatment		cryopreservation, other				yes				9823/3				BINET	C				
SP15200	CLLE-ES	PCAWG	004-0012-06TR	DO6353	4	Primary tumour - blood derived (peripheral blood)		1431	no treatment		cryopreservation, other				yes				9823/3				BINET	A				
SP13281	CLLE-ES	PCAWG	004-0012-05TD	DO6353	4	Primary tumour - blood derived (peripheral blood)		1431	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96831	CLLE-ES	PCAWG	004-0013-01ND	DO6353	4	Normal - blood derived		2317	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13283	CLLE-ES	PCAWG	005-0015-01TD	DO6354	5	Primary tumour - blood derived (peripheral blood)		1507	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP15206	CLLE-ES	PCAWG	005-0015-02TR	DO6354	5	Primary tumour - blood derived (peripheral blood)		1507	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP96833	CLLE-ES	PCAWG	005-0017-01ND	DO6354	5	Normal - blood derived		2388	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15212	CLLE-ES		007-0400-01TR	DO6356	7	Primary tumour - blood derived (peripheral blood)		3873	no treatment		cryopreservation, other								9823/3					Mutated				
SP13285	CLLE-ES		007-0020-01TD	DO6356	7	Primary tumour - blood derived (peripheral blood)		3136	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP96836	CLLE-ES		007-0021-01ND	DO6356	7	Normal - blood derived					fresh		other	frozen										Mutated				
SP15218	CLLE-ES		008-0023-01TR	DO6358	8	Primary tumour - blood derived (peripheral blood)		33	no treatment		cryopreservation, other								9823/3					Unmutated				
SP96837	CLLE-ES		008-0024-03ND	DO6358	8	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13287	CLLE-ES		008-0022-01TD	DO6358	8	Primary tumour - blood derived (peripheral blood)		33	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Unmutated				
SP15224	CLLE-ES	PCAWG	009-0026-03TR	DO6360	9	Primary tumour - blood derived (peripheral blood)		1030	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP96838	CLLE-ES	PCAWG	009-0027-01ND	DO6360	9	Normal - blood derived		3635	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13289	CLLE-ES	PCAWG	009-0026-02TD	DO6360	9	Primary tumour - blood derived (peripheral blood)		1030	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP13293	CLLE-ES	PCAWG	012-02-1TD	DO6364	12	Primary tumour - blood derived (peripheral blood)		2217	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	A				
SP15236	CLLE-ES	PCAWG	012-04-1TR	DO6364	12	Primary tumour - blood derived (peripheral blood)		2083	no treatment		cryopreservation, other				yes				9823/3				BINET	A				
SP96832	CLLE-ES	PCAWG	012-0034-01ND	DO6364	12	Normal - blood derived		3479	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13299	CLLE-ES	PCAWG	016-0040-02TD	DO6370	16	Primary tumour - blood derived (peripheral blood)		2414	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	A				
SP15254	CLLE-ES	PCAWG	016-0040-03TR	DO6370	16	Primary tumour - blood derived (peripheral blood)		2414	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP96841	CLLE-ES	PCAWG	016-0041-01ND	DO6370	16	Normal - blood derived		4863	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15260	CLLE-ES		017-0042-02TR	DO6372	17	Primary tumour - blood derived (peripheral blood)		672	no treatment		cryopreservation, other								9823/3					Unmutated				
SP96842	CLLE-ES		017-0044-01ND	DO6372	17	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13301	CLLE-ES		017-0042-01TD	DO6372	17	Primary tumour - blood derived (peripheral blood)		672	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Unmutated				
SP13303	CLLE-ES		018-0046-01TD	DO6374	18	Primary tumour - blood derived (peripheral blood)		618	immunotherapy		fresh		other	frozen					9823/3					Mutated				
SP15266	CLLE-ES		018-0045-01TR	DO6374	18	Primary tumour - blood derived (peripheral blood)		13	no treatment		cryopreservation, other								9823/3					Mutated				
SP96825	CLLE-ES		018-0046-05ND	DO6374	18	Normal - blood derived					fresh		other	frozen										Mutated				
SP13305	CLLE-ES		019-0047-01TD	DO6376	19	Primary tumour - blood derived (peripheral blood)		686	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP15272	CLLE-ES		019-01-1TR	DO6376	19	Primary tumour - blood derived (peripheral blood)		1331	no treatment		cryopreservation, other								9823/3					Mutated				
SP96843	CLLE-ES		019-0048-01ND	DO6376	19	Normal - blood derived					fresh		other	frozen										Mutated				
SP15278	CLLE-ES		020-0050-01TR	DO6378	20	Primary tumour - blood derived (peripheral blood)		1	no treatment		cryopreservation, other								9823/3					Unmutated				
SP13307	CLLE-ES	PCAWG	020-0049-01TD	DO6378	20	Primary tumour - blood derived (peripheral blood)		1	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	A				
SP96844	CLLE-ES	PCAWG	020-0051-01ND	DO6378	20	Normal - blood derived		1477	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP96845	CLLE-ES		022-0227-04ND	DO6380	22	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13309	CLLE-ES		022-0053-01TD	DO6380	22	Primary tumour - blood derived (peripheral blood)		124	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Unmutated				
SP15284	CLLE-ES		022-0053-02TR	DO6380	22	Primary tumour - blood derived (peripheral blood)		124	no treatment		cryopreservation, other								9823/3					Unmutated				
SP15290	CLLE-ES	PCAWG	023-0056-02TR	DO6382	23	Primary tumour - blood derived (peripheral blood)		178	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP96846	CLLE-ES	PCAWG	023-0219-01ND	DO6382	23	Normal - blood derived		1998	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13311	CLLE-ES	PCAWG	023-0056-01TD	DO6382	23	Primary tumour - blood derived (peripheral blood)		178	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP15314	CLLE-ES	PCAWG	027-0063-02TR	DO6390	27	Primary tumour - blood derived (peripheral blood)		829	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP13319	CLLE-ES	PCAWG	027-0063-01TD	DO6390	27	Primary tumour - blood derived (peripheral blood)		829	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96847	CLLE-ES	PCAWG	027-0220-01ND	DO6390	27	Normal - blood derived		3114	chemotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13321	CLLE-ES		029-0065-01TD	DO6392	29	Primary tumour - blood derived (peripheral blood)		49	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP15320	CLLE-ES		029-0065-02TR	DO6392	29	Primary tumour - blood derived (peripheral blood)		49	no treatment		cryopreservation, other								9823/3					Mutated				
SP96848	CLLE-ES		029-0215-01ND	DO6392	29	Normal - blood derived					fresh		other	frozen										Mutated				
SP96849	CLLE-ES	PCAWG	030-0067-01ND	DO6394	30	Normal - blood derived		2141	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15326	CLLE-ES	PCAWG	030-0066-02TR	DO6394	30	Primary tumour - blood derived (peripheral blood)		649	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP13323	CLLE-ES	PCAWG	030-0066-01TD	DO6394	30	Primary tumour - blood derived (peripheral blood)		649	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP15332	CLLE-ES	PCAWG	032-0069-02TR	DO6396	32	Primary tumour - blood derived (peripheral blood)		1322	no treatment		fresh				yes				9823/3				BINET	A				
SP13325	CLLE-ES	PCAWG	032-0069-01TD	DO6396	32	Primary tumour - blood derived (peripheral blood)		1322	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	A				
SP96850	CLLE-ES	PCAWG	032-0069-06ND	DO6396	32	Normal - blood derived		1322	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP13327	CLLE-ES	PCAWG	033-0070-01TD	DO6398	33	Primary tumour - blood derived (peripheral blood)		3595	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96851	CLLE-ES	PCAWG	033-0070-03ND	DO6398	33	Normal - blood derived		3595	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP15344	CLLE-ES	PCAWG	039-0076-05TR	DO6402	39	Primary tumour - blood derived (peripheral blood)		1174	no treatment		fresh				yes				9823/3				BINET	B				
SP96854	CLLE-ES	PCAWG	039-0076-03ND	DO6402	39	Normal - blood derived		1190	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP13331	CLLE-ES	PCAWG	039-0076-01TD	DO6402	39	Primary tumour - blood derived (peripheral blood)		1190	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96855	CLLE-ES		040-0077-01ND	DO6404	40	Normal - blood derived					fresh		other	frozen										Mutated				
SP15350	CLLE-ES		040-0088-02TR	DO6404	40	Primary tumour - blood derived (peripheral blood)		867	no treatment		cryopreservation, other								9823/3					Mutated				
SP13333	CLLE-ES		040-0088-01TD	DO6404	40	Primary tumour - blood derived (peripheral blood)		867	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP96856	CLLE-ES		041-0078-06ND	DO6406	41	Normal - blood derived					fresh		other	frozen										Mutated				
SP15356	CLLE-ES		041-0078-02TR	DO6406	41	Primary tumour - blood derived (peripheral blood)		1584	no treatment		fresh								9823/3					Mutated				
SP13335	CLLE-ES		041-0090-01TD	DO6406	41	Primary tumour - blood derived (peripheral blood)		1251	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP96859	CLLE-ES		043-0080-01ND	DO6408	43	Normal - blood derived					fresh		other	frozen										Mutated				
SP13337	CLLE-ES		043-0094-01TD	DO6408	43	Primary tumour - blood derived (peripheral blood)		13	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Mutated				
SP15368	CLLE-ES		043-0080-07TR	DO6408	43	Primary tumour - blood derived (peripheral blood)													9823/3					Mutated				
SP15374	CLLE-ES		043-01-4TR	DO6408	43	Primary tumour - blood derived (peripheral blood)		1337	chemotherapy		fresh								9823/3					Mutated				
SP13339	CLLE-ES	PCAWG	044-0092-01TD	DO6410	44	Primary tumour - blood derived (peripheral blood)		394	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96860	CLLE-ES	PCAWG	044-0081-01ND	DO6410	44	Normal - blood derived		2232	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15380	CLLE-ES	PCAWG	044-0095-01TR	DO6410	44	Primary tumour - blood derived (peripheral blood)		47	no treatment		cryopreservation, other				yes				9823/3				BINET	A				
SP15386	CLLE-ES		045-0082-05TR	DO6412	45	Primary tumour - blood derived (peripheral blood)		483	no treatment		fresh								9823/3					Mutated				
SP13341	CLLE-ES		045-0082-04TD	DO6412	45	Primary tumour - blood derived (peripheral blood)		483	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96861	CLLE-ES		045-0082-01ND	DO6412	45	Normal - blood derived					fresh		other	frozen										Mutated				
SP15398	CLLE-ES	PCAWG	048-0089-02TR	DO6418	48	Primary tumour - blood derived (peripheral blood)		512	no treatment		cryopreservation, other				yes				9823/3				BINET	C				
SP96862	CLLE-ES	PCAWG	048-0085-01ND	DO6418	48	Normal - blood derived		1245	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13347	CLLE-ES	PCAWG	048-0089-01TD	DO6418	48	Primary tumour - blood derived (peripheral blood)		512	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP13349	CLLE-ES		049-0086-01TD	DO6420	49	Primary tumour - blood derived (peripheral blood)		2669	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP15404	CLLE-ES		049-0086-02TR	DO6420	49	Primary tumour - blood derived (peripheral blood)		2669	no treatment		fresh								9823/3					Unmutated				
SP96863	CLLE-ES		049-0086-04ND	DO6420	49	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96864	CLLE-ES		051-0099-01ND	DO6422	51	Normal - blood derived					fresh		other	frozen										Mutated				
SP13351	CLLE-ES		051-0099-05TD	DO6422	51	Primary tumour - blood derived (peripheral blood)		4736	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15410	CLLE-ES		051-0099-06TR	DO6422	51	Primary tumour - blood derived (peripheral blood)		4736	no treatment		fresh								9823/3					Mutated				
SP13353	CLLE-ES		052-0103-01TD	DO6424	52	Primary tumour - blood derived (peripheral blood)		2154	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP15416	CLLE-ES		052-0103-04TR	DO6424	52	Primary tumour - blood derived (peripheral blood)		2154	no treatment		fresh								9823/3					Unmutated				
SP96865	CLLE-ES		052-0103-02ND	DO6424	52	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15422	CLLE-ES		053-0104-03TR	DO6426	53	Primary tumour - blood derived (peripheral blood)		3256	no treatment		fresh								9823/3					Unmutated				
SP13355	CLLE-ES		053-0104-02TD	DO6426	53	Primary tumour - blood derived (peripheral blood)		3256	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP96866	CLLE-ES		053-2040-01ND	DO6426	53	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15440	CLLE-ES	PCAWG	063-0127-02TR	DO6430	63	Primary tumour - blood derived (peripheral blood)		207	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP96869	CLLE-ES	PCAWG	063-0126-02ND	DO6430	63	Normal - blood derived		1994	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13359	CLLE-ES	PCAWG	063-0127-01TD	DO6430	63	Primary tumour - blood derived (peripheral blood)		207	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP15446	CLLE-ES	PCAWG	064-0128-08TR	DO6432	64	Primary tumour - blood derived (peripheral blood)		1953	no treatment		fresh				yes				9823/3				BINET	B				
SP13361	CLLE-ES	PCAWG	064-0128-01TD	DO6432	64	Primary tumour - blood derived (peripheral blood)		1953	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96870	CLLE-ES	PCAWG	064-0128-04ND	DO6432	64	Normal - blood derived		1953	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP96871	CLLE-ES	PCAWG	082-01-1ND	DO6434	82	Normal - blood derived		2509	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15452	CLLE-ES	PCAWG	082-02-2TR	DO6434	82	Primary tumour - blood derived (peripheral blood)		338	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP13363	CLLE-ES	PCAWG	082-02-1TD	DO6434	82	Primary tumour - blood derived (peripheral blood)		338	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP15458	CLLE-ES		083-01-3TR	DO6436	83	Primary tumour - blood derived (peripheral blood)		307	no treatment		cryopreservation, other								9823/3					Unmutated				
SP13365	CLLE-ES	PCAWG	083-01-2TD	DO6436	83	Primary tumour - blood derived (peripheral blood)		307	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96872	CLLE-ES	PCAWG	083-1513-01ND	DO6436	83	Normal - blood derived		1491	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15470	CLLE-ES	PCAWG	090-02-3TR	DO6438	90	Primary tumour - blood derived (peripheral blood)		665	no treatment		cryopreservation, other				yes				9823/3				BINET	B				
SP13367	CLLE-ES	PCAWG	090-02-1TD	DO6438	90	Primary tumour - blood derived (peripheral blood)		665	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96873	CLLE-ES	PCAWG	090-01-1ND	DO6438	90	Normal - blood derived		2553	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP13369	CLLE-ES		100-02-2TD	DO6440	100	Primary tumour - blood derived (peripheral blood)		1	no treatment		cryopreservation in liquid nitrogen (dead tissue)		other	frozen					9823/3					Unmutated				
SP15476	CLLE-ES		100-02-3TR	DO6440	100	Primary tumour - blood derived (peripheral blood)		1	no treatment		cryopreservation, other								9823/3					Unmutated				
SP96876	CLLE-ES		100-01-1ND	DO6440	100	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13373	CLLE-ES		110-0218-04TD	DO6444	110	Primary tumour - blood derived (peripheral blood)		2779	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96877	CLLE-ES		110-0218-01ND	DO6444	110	Normal - blood derived					fresh		other	frozen										Mutated				
SP15488	CLLE-ES		110-0218-06TR	DO6444	110	Primary tumour - blood derived (peripheral blood)		2779	no treatment		fresh								9823/3					Mutated				
SP15494	CLLE-ES		117-01-2TR	DO6446	117	Primary tumour - blood derived (peripheral blood)		6959	no treatment		fresh								9823/3					Mutated				
SP13375	CLLE-ES		117-01-1TD	DO6446	117	Primary tumour - blood derived (peripheral blood)		6959	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96878	CLLE-ES		117-01-3ND	DO6446	117	Normal - blood derived					fresh		other	frozen										Mutated				
SP13377	CLLE-ES		124-01-1TD	DO6448	124	Primary tumour - blood derived (peripheral blood)		2723	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15500	CLLE-ES		124-01-2TR	DO6448	124	Primary tumour - blood derived (peripheral blood)		2723	no treatment		fresh								9823/3					Mutated				
SP96879	CLLE-ES		124-01-4ND	DO6448	124	Normal - blood derived					fresh		other	frozen										Mutated				
SP96880	CLLE-ES		136-02-1ND	DO6454	136	Normal - blood derived					fresh		other	frozen										Mutated				
SP15524	CLLE-ES		136-02-5TR	DO6454	136	Primary tumour - blood derived (peripheral blood)		6944	no treatment		fresh								9823/3					Mutated				
SP13383	CLLE-ES		136-02-3TD	DO6454	136	Primary tumour - blood derived (peripheral blood)		6944	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96883	CLLE-ES		144-01-2ND	DO6458	144	Normal - blood derived					fresh		other	frozen										Mutated				
SP13387	CLLE-ES		144-01-1TD	DO6458	144	Primary tumour - blood derived (peripheral blood)		7994	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15542	CLLE-ES		144-01-3TR	DO6458	144	Primary tumour - blood derived (peripheral blood)		7994	no treatment		fresh								9823/3					Mutated				
SP96886	CLLE-ES		146-01-2ND	DO6460	146	Normal - blood derived					fresh		other	frozen										Mutated				
SP15554	CLLE-ES		146-01-6TR	DO6460	146	Primary tumour - blood derived (peripheral blood)		2739	no treatment		fresh								9823/3					Mutated				
SP13389	CLLE-ES		146-01-5TD	DO6460	146	Primary tumour - blood derived (peripheral blood)		2739	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15566	CLLE-ES		152-01-5TR	DO6464	152	Primary tumour - blood derived (peripheral blood)		1727	no treatment		fresh								9823/3					Mutated				
SP96889	CLLE-ES		152-01-1ND	DO6464	152	Normal - blood derived					fresh		other	frozen										Mutated				
SP13393	CLLE-ES		152-01-4TD	DO6464	152	Primary tumour - blood derived (peripheral blood)		1727	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96890	CLLE-ES		155-01-4ND	DO6466	155	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15578	CLLE-ES		155-01-2TR	DO6466	155	Primary tumour - blood derived (peripheral blood)		3236	no treatment		fresh								9823/3					Unmutated				
SP13395	CLLE-ES		155-01-1TD	DO6466	155	Primary tumour - blood derived (peripheral blood)		3236	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP15584	CLLE-ES		156-01-2TR	DO6468	156	Primary tumour - blood derived (peripheral blood)		10	no treatment		fresh								9823/3					Mutated				
SP96891	CLLE-ES		156-01-4ND	DO6468	156	Normal - blood derived					fresh		other	frozen										Mutated				
SP13397	CLLE-ES		156-01-1TD	DO6468	156	Primary tumour - blood derived (peripheral blood)		10	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13399	CLLE-ES	PCAWG	157-01-1TD	DO6470	157	Primary tumour - blood derived (peripheral blood)		54	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP15590	CLLE-ES	PCAWG	157-01-3TR	DO6470	157	Primary tumour - blood derived (peripheral blood)		54	no treatment		fresh				yes				9823/3				BINET	B				
SP96892	CLLE-ES	PCAWG	157-01-4ND	DO6470	157	Normal - blood derived		54	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP13401	CLLE-ES		159-01-1TD	DO6472	159	Primary tumour - blood derived (peripheral blood)		4419	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15602	CLLE-ES		159-01-3TR	DO6472	159	Primary tumour - blood derived (peripheral blood)		4419	no treatment		fresh								9823/3					Mutated				
SP96893	CLLE-ES		159-01-5ND	DO6472	159	Normal - blood derived					fresh		other	frozen										Mutated				
SP13403	CLLE-ES		166-01-4TD	DO6474	166	Primary tumour - blood derived (peripheral blood)		770	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP96896	CLLE-ES	PCAWG	166-01-1ND	DO6474	166	Normal - blood derived		770	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP15608	CLLE-ES	PCAWG	166-01-6TR	DO6474	166	Primary tumour - blood derived (peripheral blood)		770	no treatment		fresh				yes				9823/3				BINET	A				
SP115070	CLLE-ES	PCAWG	166-07-01TD	DO6474	166	Primary tumour - blood derived (peripheral blood)		1645	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96897	CLLE-ES		168-02-1ND	DO6476	168	Normal - blood derived					fresh		other	frozen										Mutated				
SP15614	CLLE-ES		168-02-8TR	DO6476	168	Primary tumour - blood derived (peripheral blood)		4893	no treatment		fresh								9823/3					Mutated				
SP13405	CLLE-ES		168-02-2TD	DO6476	168	Primary tumour - blood derived (peripheral blood)		4893	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13407	CLLE-ES		170-01-3TD	DO6478	170	Primary tumour - blood derived (peripheral blood)		5054	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15620	CLLE-ES		170-01-6TR	DO6478	170	Primary tumour - blood derived (peripheral blood)		5054	no treatment		fresh								9823/3					Mutated				
SP96898	CLLE-ES		170-01-1ND	DO6478	170	Normal - blood derived					fresh		other	frozen										Mutated				
SP96899	CLLE-ES		171-01-1ND	DO6480	171	Normal - blood derived					fresh		other	frozen										Mutated				
SP15626	CLLE-ES		171-01-3TR	DO6480	171	Primary tumour - blood derived (peripheral blood)		6904	no treatment		fresh								9823/3					Mutated				
SP13409	CLLE-ES		171-01-2TD	DO6480	171	Primary tumour - blood derived (peripheral blood)		6904	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13411	CLLE-ES		172-01-1TD	DO6482	172	Primary tumour - blood derived (peripheral blood)		6090	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96900	CLLE-ES		172-01-4ND	DO6482	172	Normal - blood derived					fresh		other	frozen										Mutated				
SP15632	CLLE-ES		172-01-3TR	DO6482	172	Primary tumour - blood derived (peripheral blood)		6090	no treatment		fresh								9823/3					Mutated				
SP15638	CLLE-ES		173-01-4TR	DO6484	173	Primary tumour - blood derived (peripheral blood)		3878	chemotherapy		fresh								9823/3					Mutated				
SP13413	CLLE-ES		173-01-3TD	DO6484	173	Primary tumour - blood derived (peripheral blood)		3878	immunotherapy		fresh		other	frozen					9823/3					Mutated				
SP96901	CLLE-ES		173-01-1ND	DO6484	173	Normal - blood derived					fresh		other	frozen										Mutated				
SP96902	CLLE-ES		174-01-1ND	DO6486	174	Normal - blood derived					fresh		other	frozen										Mutated				
SP15644	CLLE-ES		174-01-4TR	DO6486	174	Primary tumour - blood derived (peripheral blood)		2857	no treatment		fresh								9823/3					Mutated				
SP13415	CLLE-ES		174-01-3TD	DO6486	174	Primary tumour - blood derived (peripheral blood)		2857	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13417	CLLE-ES		175-01-3TD	DO6488	175	Primary tumour - blood derived (peripheral blood)		3064	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15650	CLLE-ES		175-01-4TR	DO6488	175	Primary tumour - blood derived (peripheral blood)		3064	no treatment		fresh								9823/3					Mutated				
SP96903	CLLE-ES		175-01-1ND	DO6488	175	Normal - blood derived					fresh		other	frozen										Mutated				
SP15656	CLLE-ES	PCAWG	181-01-4TR	DO6492	181	Primary tumour - blood derived (peripheral blood)		1696	no treatment		fresh				yes				9823/3				BINET	C				
SP13421	CLLE-ES	PCAWG	181-01-3TD	DO6492	181	Primary tumour - blood derived (peripheral blood)		1696	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	C				
SP96906	CLLE-ES	PCAWG	181-01-1ND	DO6492	181	Normal - blood derived		1696	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP15662	CLLE-ES		182-01-7TR	DO6494	182	Primary tumour - blood derived (peripheral blood)		868	no treatment		fresh								9823/3					Unmutated				
SP96907	CLLE-ES		182-01-1ND	DO6494	182	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13423	CLLE-ES		182-01-4TD	DO6494	182	Primary tumour - blood derived (peripheral blood)		868	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP15668	CLLE-ES		184-01-5TR	DO6496	184	Primary tumour - blood derived (peripheral blood)		40	no treatment		fresh								9823/3					Unmutated				
SP96908	CLLE-ES		184-01-1ND	DO6496	184	Normal - blood derived					fresh		other	frozen										Unmutated				
SP13425	CLLE-ES		184-01-4TD	DO6496	184	Primary tumour - blood derived (peripheral blood)		40	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP13427	CLLE-ES		185-01-6TD	DO6498	185	Primary tumour - blood derived (peripheral blood)		1909	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96909	CLLE-ES		185-01-2ND	DO6498	185	Normal - blood derived					fresh		other	frozen										Mutated				
SP15674	CLLE-ES		185-01-8TR	DO6498	185	Primary tumour - blood derived (peripheral blood)		1909	no treatment		fresh								9823/3					Mutated				
SP15680	CLLE-ES		186-01-8TR	DO6501	186	Primary tumour - blood derived (peripheral blood)		7990	no treatment		fresh								9823/3					Unmutated				
SP13430	CLLE-ES		186-01-6TD	DO6501	186	Primary tumour - blood derived (peripheral blood)		7990	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP96910	CLLE-ES		186-01-10ND	DO6501	186	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15686	CLLE-ES	PCAWG	188-01-13TR	DO6504	188	Primary tumour - blood derived (peripheral blood)		2204	no treatment		fresh				yes				9823/3				BINET	B				
SP13433	CLLE-ES	PCAWG	188-01-2TD	DO6504	188	Primary tumour - blood derived (peripheral blood)		2204	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	B				
SP96911	CLLE-ES	PCAWG	188-01-8ND	DO6504	188	Normal - blood derived		2204	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP96912	CLLE-ES		189-01-5ND	DO6507	189	Normal - blood derived					fresh		other	frozen										Mutated				
SP15692	CLLE-ES		189-01-3TR	DO6507	189	Primary tumour - blood derived (peripheral blood)		1693	no treatment		fresh								9823/3					Mutated				
SP13436	CLLE-ES		189-01-1TD	DO6507	189	Primary tumour - blood derived (peripheral blood)		1693	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13439	CLLE-ES		191-01-3TD	DO6510	191	Primary tumour - blood derived (peripheral blood)		4236	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96913	CLLE-ES		191-01-1ND	DO6510	191	Normal - blood derived					fresh		other	frozen										Mutated				
SP15698	CLLE-ES		191-01-8TR	DO6510	191	Primary tumour - blood derived (peripheral blood)		4236	no treatment		fresh								9823/3					Mutated				
SP96914	CLLE-ES	PCAWG	192-01-2ND	DO6513	192	Normal - blood derived		49	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP13442	CLLE-ES	PCAWG	192-01-4TD	DO6513	192	Primary tumour - blood derived (peripheral blood)		49	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	A				
SP15704	CLLE-ES	PCAWG	192-01-7TR	DO6513	192	Primary tumour - blood derived (peripheral blood)		41	no treatment		fresh				yes				9823/3				BINET	A				
SP15710	CLLE-ES		193-01-3TR	DO6516	193	Primary tumour - blood derived (peripheral blood)		1589	no treatment		fresh								9823/3					Mutated				
SP13445	CLLE-ES		193-01-1TD	DO6516	193	Primary tumour - blood derived (peripheral blood)		1589	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96915	CLLE-ES		193-01-6ND	DO6516	193	Normal - blood derived					fresh		other	frozen										Mutated				
SP96916	CLLE-ES		194-01-6ND	DO6519	194	Normal - blood derived					fresh		other	frozen										Mutated				
SP13448	CLLE-ES		194-01-2TD	DO6519	194	Primary tumour - blood derived (peripheral blood)		7467	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15716	CLLE-ES		194-01-4TR	DO6519	194	Primary tumour - blood derived (peripheral blood)		7467	no treatment		fresh								9823/3					Mutated				
SP96917	CLLE-ES		195-01-1ND	DO6522	195	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15722	CLLE-ES		195-01-11TR	DO6522	195	Primary tumour - blood derived (peripheral blood)		2007	no treatment		fresh								9823/3					Unmutated				
SP13451	CLLE-ES		195-01-5TD	DO6522	195	Primary tumour - blood derived (peripheral blood)		2007	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP13454	CLLE-ES		197-01-3TD	DO6525	197	Primary tumour - blood derived (peripheral blood)		1612	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96918	CLLE-ES		197-01-1ND	DO6525	197	Normal - blood derived					fresh		other	frozen										Mutated				
SP15728	CLLE-ES		197-01-6TR	DO6525	197	Primary tumour - blood derived (peripheral blood)		1612	no treatment		fresh								9823/3					Mutated				
SP15734	CLLE-ES		264-01-14TR	DO6528	264	Primary tumour - blood derived (peripheral blood)		721	no treatment		fresh								9823/3					Mutated				
SP13457	CLLE-ES		264-01-7TD	DO6528	264	Primary tumour - blood derived (peripheral blood)		721	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96919	CLLE-ES		264-01-1ND	DO6528	264	Normal - blood derived					fresh		other	frozen										Mutated				
SP13460	CLLE-ES		267-01-6TD	DO6531	267	Primary tumour - blood derived (peripheral blood)		3424	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15740	CLLE-ES		267-01-9TR	DO6531	267	Primary tumour - blood derived (peripheral blood)		3424	no treatment		fresh								9823/3					Mutated				
SP96922	CLLE-ES		267-01-2ND	DO6531	267	Normal - blood derived					fresh		other	frozen										Mutated				
SP15746	CLLE-ES		270-01-5TR	DO6534	270	Primary tumour - blood derived (peripheral blood)		2580	no treatment		fresh								9823/3					Unmutated				
SP13463	CLLE-ES		270-01-2TD	DO6534	270	Primary tumour - blood derived (peripheral blood)		2580	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP96923	CLLE-ES		270-01-1ND	DO6534	270	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96926	CLLE-ES		273-01-1ND	DO6537	273	Normal - blood derived					fresh		other	frozen										Mutated				
SP13466	CLLE-ES		273-01-5TD	DO6537	273	Primary tumour - blood derived (peripheral blood)		3003	no treatment		fresh		other	frozen					9823/3					Mutated				
SP115000	CLLE-ES		273-01-8TR	DO6537	273	Primary tumour - blood derived (peripheral blood)		3003	no treatment		fresh		frozen, -70 freezer						9823/3					Mutated				
SP96927	CLLE-ES		274-01-2ND	DO6540	274	Normal - blood derived					fresh		other	frozen										Mutated				
SP15752	CLLE-ES		274-01-8TR	DO6540	274	Primary tumour - blood derived (peripheral blood)		3057	no treatment		fresh								9823/3					Mutated				
SP13469	CLLE-ES		274-01-3TD	DO6540	274	Primary tumour - blood derived (peripheral blood)		3057	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15758	CLLE-ES		275-01-3TR	DO6543	275	Primary tumour - blood derived (peripheral blood)		882	no treatment		fresh								9823/3					Unmutated				
SP13472	CLLE-ES		275-01-2TD	DO6543	275	Primary tumour - blood derived (peripheral blood)		882	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP96928	CLLE-ES		275-01-1ND	DO6543	275	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15764	CLLE-ES		276-01-7TR	DO6546	276	Primary tumour - blood derived (peripheral blood)		1558	no treatment		fresh								9823/3					Mutated				
SP13475	CLLE-ES		276-01-4TD	DO6546	276	Primary tumour - blood derived (peripheral blood)		1558	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96929	CLLE-ES		276-01-1ND	DO6546	276	Normal - blood derived					fresh		other	frozen										Mutated				
SP13481	CLLE-ES	PCAWG	278-01-4TD	DO6552	278	Primary tumour - blood derived (peripheral blood)		2282	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	C				
SP15770	CLLE-ES	PCAWG	278-01-8TR	DO6552	278	Primary tumour - blood derived (peripheral blood)		2282	no treatment		fresh				yes				9823/3				BINET	C				
SP96930	CLLE-ES	PCAWG	278-01-10ND	DO6552	278	Normal - blood derived		2282	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP15776	CLLE-ES		280-01-7TR	DO6555	280	Primary tumour - blood derived (peripheral blood)		4271	no treatment		fresh								9823/3					Mutated				
SP96933	CLLE-ES		280-01-1ND	DO6555	280	Normal - blood derived					fresh		other	frozen										Mutated				
SP13484	CLLE-ES		280-01-4TD	DO6555	280	Primary tumour - blood derived (peripheral blood)		4271	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13487	CLLE-ES	PCAWG	282-01-12TD	DO6558	282	Primary tumour - blood derived (peripheral blood)		276	no treatment		fresh		frozen, -70 freezer		yes				9823/3				BINET	A				
SP96934	CLLE-ES	PCAWG	282-01-4ND	DO6558	282	Normal - blood derived		276	no treatment		fresh		frozen, -70 freezer		yes				9823/3									
SP15782	CLLE-ES	PCAWG	282-01-17TR	DO6558	282	Primary tumour - blood derived (peripheral blood)		276	no treatment		fresh				yes				9823/3				BINET	A				
SP96935	CLLE-ES	PCAWG	290-0654-03ND	DO6561	290	Normal - blood derived		647	combined chemo+immunotherapy		fresh		frozen, -70 freezer		yes				9823/3									
SP15794	CLLE-ES	PCAWG	290-1950-02TR	DO6561	290	Primary tumour - blood derived (peripheral blood)		28	no treatment		cryopreservation, other				yes				9823/3				BINET	A				
SP13490	CLLE-ES	PCAWG	290-1950-01TD	DO6561	290	Primary tumour - blood derived (peripheral blood)		28	no treatment		cryopreservation, other		frozen, -70 freezer		yes				9823/3				BINET	A				
SP15878	CLLE-ES		319-01-2TR	DO6615	319	Primary tumour - blood derived (peripheral blood)		2338	no treatment		fresh								9823/3					Mutated				
SP96936	CLLE-ES		319-01-3ND	DO6615	319	Normal - blood derived					fresh		other	frozen										Mutated				
SP13544	CLLE-ES		319-01-1TD	DO6615	319	Primary tumour - blood derived (peripheral blood)		2338	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15890	CLLE-ES		322-01-2TR	DO6620	322	Primary tumour - blood derived (peripheral blood)		4025	no treatment		fresh								9823/3					Mutated				
SP96939	CLLE-ES		322-01-3ND	DO6620	322	Normal - blood derived					fresh		other	frozen										Mutated				
SP13549	CLLE-ES		322-01-1TD	DO6620	322	Primary tumour - blood derived (peripheral blood)		4025	no treatment		fresh		other	frozen					9823/3					Mutated				
SP13554	CLLE-ES		323-01-1TD	DO6625	323	Primary tumour - blood derived (peripheral blood)		0	no treatment		fresh		other	frozen					9823/3					Mutated				
SP96940	CLLE-ES		323-01-3ND	DO6625	323	Normal - blood derived					fresh		other	frozen										Mutated				
SP15896	CLLE-ES		323-01-2TR	DO6625	323	Primary tumour - blood derived (peripheral blood)		0	no treatment		fresh								9823/3					Mutated				
SP96941	CLLE-ES		324-01-3ND	DO6630	324	Normal - blood derived					fresh		other	frozen										Mutated				
SP15902	CLLE-ES		324-01-7TR	DO6630	324	Primary tumour - blood derived (peripheral blood)		1696	no treatment		fresh								9823/3					Mutated				
SP13559	CLLE-ES		324-01-1TD	DO6630	324	Primary tumour - blood derived (peripheral blood)		1696	no treatment		fresh		other	frozen					9823/3					Mutated				
SP15908	CLLE-ES		325-01-7TR	DO6635	325	Primary tumour - blood derived (peripheral blood)		19	no treatment		fresh								9823/3					Unmutated				
SP13564	CLLE-ES		325-01-1TD	DO6635	325	Primary tumour - blood derived (peripheral blood)		19	no treatment		fresh		other	frozen					9823/3					Unmutated				
SP96942	CLLE-ES		325-01-3ND	DO6635	325	Normal - blood derived					fresh		other	frozen										Unmutated				
SP96943	CLLE-ES		326-01-3ND	DO6640	326	Normal - blood derived					fresh		other	frozen										Unmutated				
SP15914	CLLE-ES		326-01-2TR	DO6640	326	Primary tumour - blood derived (peripheral blood)		2754	immunotherapy		fresh								9823/3					Unmutated				
SP13569	CLLE-ES		326-01-1TD	DO6640	326	Primary tumour - blood derived (peripheral blood)		2754	immunotherapy		fresh		other	frozen					9823/3					Unmutated				
SP13635	CLLE-ES		375-1099-15TD	DO6706	375	Primary tumour - blood derived (peripheral blood)		3233	no treatment		fresh		other	frozen					9823/3					Mutated				
SP16046	CLLE-ES		375-1099-02TR	DO6706	375	Primary tumour - blood derived (peripheral blood)		3233	no treatment		fresh								9823/3					Mutated				
SP96946	CLLE-ES		375-1099-08ND	DO6706	375	Normal - blood derived					fresh		other	frozen										Mutated				
